FR2940120B1 - Formulation pour l'administration par voie trans-muqueuse de setrons - Google Patents

Formulation pour l'administration par voie trans-muqueuse de setrons

Info

Publication number
FR2940120B1
FR2940120B1 FR0807258A FR0807258A FR2940120B1 FR 2940120 B1 FR2940120 B1 FR 2940120B1 FR 0807258 A FR0807258 A FR 0807258A FR 0807258 A FR0807258 A FR 0807258A FR 2940120 B1 FR2940120 B1 FR 2940120B1
Authority
FR
France
Prior art keywords
setrons
formulation
transmucosal delivery
transmucosal
delivery
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0807258A
Other languages
English (en)
Other versions
FR2940120A1 (fr
Inventor
Philippe Perovitch
Marc Maury
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0807258A priority Critical patent/FR2940120B1/fr
Application filed by Individual filed Critical Individual
Priority to CA2747846A priority patent/CA2747846C/fr
Priority to CN2009801494684A priority patent/CN102245209A/zh
Priority to PCT/FR2009/052590 priority patent/WO2010070236A1/fr
Priority to JP2011541565A priority patent/JP5811404B2/ja
Priority to US13/140,745 priority patent/US20110251233A1/en
Priority to EP09805726A priority patent/EP2379110A1/fr
Priority to RU2011129781/15A priority patent/RU2574946C2/ru
Priority to BRPI0923379-2A priority patent/BRPI0923379A2/pt
Publication of FR2940120A1 publication Critical patent/FR2940120A1/fr
Application granted granted Critical
Publication of FR2940120B1 publication Critical patent/FR2940120B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR0807258A 2008-12-19 2008-12-19 Formulation pour l'administration par voie trans-muqueuse de setrons Expired - Fee Related FR2940120B1 (fr)

Priority Applications (9)

Application Number Priority Date Filing Date Title
FR0807258A FR2940120B1 (fr) 2008-12-19 2008-12-19 Formulation pour l'administration par voie trans-muqueuse de setrons
CN2009801494684A CN102245209A (zh) 2008-12-19 2009-12-17 用于通过颊透粘膜途径来施用司琼类的制剂
PCT/FR2009/052590 WO2010070236A1 (fr) 2008-12-19 2009-12-17 Formulation pour l'administration par voie trans-muqueuse buccale de setrons
JP2011541565A JP5811404B2 (ja) 2008-12-19 2009-12-17 セトロンを頬側経粘膜投与するための処方物（ｆｏｒｍｕｌａｔｉｏｎ）
CA2747846A CA2747846C (fr) 2008-12-19 2009-12-17 Formulation pour l'administration par voie trans-muqueuse buccale de setrons
US13/140,745 US20110251233A1 (en) 2008-12-19 2009-12-17 Formulation for the buccal transmucosal administration of setrons
EP09805726A EP2379110A1 (fr) 2008-12-19 2009-12-17 Formulation pour l'administration par voie trans-muqueuse buccale de setrons
RU2011129781/15A RU2574946C2 (ru) 2008-12-19 2009-12-17 Лекарственная форма для чресслизистого перорального введения сетронов
BRPI0923379-2A BRPI0923379A2 (pt) 2008-12-19 2009-12-17 Formulação para administração por via transmucosa oral de setronas

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0807258A FR2940120B1 (fr) 2008-12-19 2008-12-19 Formulation pour l'administration par voie trans-muqueuse de setrons

Publications (2)

Publication Number Publication Date
FR2940120A1 FR2940120A1 (fr) 2010-06-25
FR2940120B1 true FR2940120B1 (fr) 2012-07-13

Family

ID=40908503

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0807258A Expired - Fee Related FR2940120B1 (fr) 2008-12-19 2008-12-19 Formulation pour l'administration par voie trans-muqueuse de setrons

Country Status (8)

Country Link
US (1) US20110251233A1 (fr)
EP (1) EP2379110A1 (fr)
JP (1) JP5811404B2 (fr)
CN (1) CN102245209A (fr)
BR (1) BRPI0923379A2 (fr)
CA (1) CA2747846C (fr)
FR (1) FR2940120B1 (fr)
WO (1) WO2010070236A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102552124B (zh) * 2011-01-12 2014-07-02 韩斌 雷莫司琼的液体药物组合物
FR3031668A1 (fr) 2015-01-20 2016-07-22 Philippe Perovitch Dispositif d'administration d'un principe actif par voie per-muqueuse buccale.
FR3053244A1 (fr) 2016-07-01 2018-01-05 Philippe Perovitch Dispositif d'administration d'au moins un principe actif par voie per-muqueuse buccale.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040136914A1 (en) 1997-10-01 2004-07-15 Dugger Harry A. Buccal, polar and non-polar spray containing ondansetron
DE19929197A1 (de) * 1999-06-25 2000-12-28 Novosis Pharma Ag Transdermalsysteme zur Abgabe von 5-HT3-Rezeptor-Antagonisten und ihre Verwendung zur antiemitischen Behandlung
US20070225379A1 (en) * 2001-08-03 2007-09-27 Carrara Dario Norberto R Transdermal delivery of systemically active central nervous system drugs
EP2767163A1 (fr) * 2005-02-17 2014-08-20 Abbott Laboratories Administration par voie transmuqueuse de compositions médicamenteuses pour le traitement et la prévention de troubles chez les animaux
FR2906140B1 (fr) * 2006-09-22 2008-12-05 Philippe Perovitch Forme galenique pour l'administration par voie trans-muqueuse de principes actifs
CA2673049C (fr) * 2006-12-22 2016-02-23 Novadel Pharma Inc. Preparations antinauseeuses a pulveriser, a usage oral, stables, et methodes associees

Also Published As

Publication number Publication date
CA2747846C (fr) 2017-03-07
FR2940120A1 (fr) 2010-06-25
US20110251233A1 (en) 2011-10-13
EP2379110A1 (fr) 2011-10-26
JP2012512851A (ja) 2012-06-07
CA2747846A1 (fr) 2010-06-24
CN102245209A (zh) 2011-11-16
BRPI0923379A2 (pt) 2015-07-21
WO2010070236A1 (fr) 2010-06-24
JP5811404B2 (ja) 2015-11-11
RU2011129781A (ru) 2013-01-27

Similar Documents

Publication Publication Date Title
HK1164059A1 (en) Compositions for drug administration
EP2012751A4 (fr) Nouvelles nanoparticules destinees a la delivrance d'agents actifs
DK2346495T4 (da) Farmaceutisk formulering 514
FR2906140B1 (fr) Forme galenique pour l'administration par voie trans-muqueuse de principes actifs
EP2130552A4 (fr) Composition pharmaceutique comportant un anticorps anti-grp 78 en tant qu'ingredient actif
IL211099A0 (en) Formulation for oral administration of proteins
BRPI0913379A2 (pt) formulações farmacêuticas sólidas compreendendo bibw 2992
FR2940911B1 (fr) Formulation pour l'administration par voie trans-muqueuse buccale de molecules antalgiques et/ou anti-spasmodiques
AP3542A (en) Anti-malarial pharmaceutical composition
DK2391351T3 (da) Farmaceutisk sammensætning omfattende 2-oxo-1-pyrrolidinderivater
EP2150235A4 (fr) Formulation de capsules enrobées de nanoparticules pour administration dermique de médicament
IL208325A0 (en) Stabilizing lipis compositions for oral pharmaceutical agents
FR2940116B1 (fr) Formulation pour l'administration d'hypolipemiant par voie trans-muqueuse buccale
BRPI0922888A2 (pt) administração combinada de fármaco
IT1392547B1 (it) Dispositivo per l'infusione di farmaci
FR2940120B1 (fr) Formulation pour l'administration par voie trans-muqueuse de setrons
FR2980976B1 (fr) Composition pharmaceutique pour l'administration par voie nasale de la metopimazine
BRPI0913709A2 (pt) "formulação farmacêutica"
BRPI0906045A2 (pt) "composição farmacêutica para administração nasal"
ITMI20061741A1 (it) Composizioni farmaceutiche per la somministrazione orale di sostanze proteiche
FR2968995B1 (fr) Composition pharmaceutioue pour une administration par voie orale destinee a eviter le mesusage
ZA201102405B (en) Pharmaceutical composition for oral administration
BRPI0906346A2 (pt) "composição farmacêutica de liberação prolongada"
FR2936933B1 (fr) Administration par voie orale de complements nutritionnels pour animaux
EP1993591A4 (fr) Administration ciblee de composes pharmaceutiques

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 8

PLFP Fee payment

Year of fee payment: 9

PLFP Fee payment

Year of fee payment: 10

PLFP Fee payment

Year of fee payment: 12

PLFP Fee payment

Year of fee payment: 13

PLFP Fee payment

Year of fee payment: 14

ST Notification of lapse

Effective date: 20230808